Article

Identification Sixteen Metabolic Genes as Potential Biomarkers for Colon Adenocarcinoma

2020-11-18

Abstract excerpt

<h4>Purpose: </h4> Colon adenocarcinoma is the most common primary malignant tumor of the digestive tract. It is still important to find important markers that affect the prognosis of COAD. This research aims to identify some key prognosis-related metabolic genes (PRMG) and establish a clinical prognosis model for COAD patients. Method We used The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) to obt...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0a45ea13-662e-5d23-bac8-aaafa9c305f7
DOI: 10.22541/au.160568747.70023580/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification Sixteen Metabolic Genes as Potential Biomarkers for Colon AdenocarcinomaDOI 10.22541/au.160568747.70023580/v1Read

Identification Sixteen Metabolic Genes as Potential Biomarkers for Colon Adenocarcinoma Semantic proximity Read

Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal AdenocarcinomaSemantic proximity Read

The Prognostic Value of Metabolic Genes in Gastric AdenocarcinomaSemantic proximity Read

Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genesSemantic proximity Read

Identification of One-carbon metabolism-related gene signature and Analysis of the role of m6A and miRNAs/circRNAs for colon adenocarcinomaSemantic proximity Read

Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinomaSemantic proximity Read

Deciphering a hydrogen sulfide-related signature to supervise prognosis and therapeutic response in colon adenocarcinomaSemantic proximity Read

Glycerophosphodiester phosphodiesterase 1 (GDE1) acts as a potential tumor suppressor and is a novel therapeutic target for non-mucin-producing colon adenocarcinomaSemantic proximity Read

Survival-associated Metabolic Genes in Colon and Rectal CancersSemantic proximity Read

Development of a fatty acid metabolism-related genes predictive model in colon cancer patientsSemantic proximity Read

FCHO1 Is a Prognostic Biomarker of Colon Adenocarcinoma and Associated with Immune Infiltration and GlycolysisSemantic proximity Read

Prognostic implications of metabolism-associated gene signatures in colorectal cancerSemantic proximity Read